Meeder Advisory Services »

Royalty Pharma shares owned by Meeder Advisory Services

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Meeder Advisory Services from 13F filings

Historical chart of Meeder Advisory Services investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Meeder Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Meeder Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $222k 7.3k 30.37
2023-12-31 $210k 7.5k 28.09

More positions owned by Meeder Advisory Services

Ishares Tr National Mun Etf (MUB)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Amazon (AMZN)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Meta Platforms Cl A (META)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)

View all positions for Meeder Advisory Services

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
FMR
BlackRock
Baillie Gifford & Co
Viking Global Investors
Adage Capital Partners GP
Jpmorgan Chase & Co
Geode Capital Management
Unisphere Establishment
Millennium Management
Siguler Guff Advisers
Legal & General Group
Northern Trust
Suvretta Capital Management

View all funds holding Royalty Pharma